BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 5127773)

  • 21. Experimental induction of lung cancer in rat and mouse with 20-methylcholanthrene in Freund's adjuvant.
    Yasuhira K
    Acta Pathol Jpn; 1967 Nov; 17(4):479-93. PubMed ID: 5631388
    [No Abstract]   [Full Text] [Related]  

  • 22. [Adjuvants in specific desensitizing therapy].
    Dal Bo S
    Folia Allergol (Roma); 1969; 16(4):424-5. PubMed ID: 5400583
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides.
    Salgaller ML; Marincola FM; Cormier JN; Rosenberg SA
    Cancer Res; 1996 Oct; 56(20):4749-57. PubMed ID: 8840994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of the inflammatory response in the rat TMJ with increasing doses of complete Freund's adjuvant.
    Harper RP; Kerins CA; McIntosh JE; Spears R; Bellinger LL
    Osteoarthritis Cartilage; 2001 Oct; 9(7):619-24. PubMed ID: 11597174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early suppression with late acceleration of syngeneic tumor growth by Freund's adjuvant.
    Cruse JM
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Feb; 132(2):196-201. PubMed ID: 4230697
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental carcinogenesis in the urinary bladder against a background of Freund adjuvant and levamisole administration].
    Anichkov NM; Lomakina II; ZubzhitskiÄ­ IuN
    Biull Eksp Biol Med; 1980 Jun; 89(6):720-3. PubMed ID: 7397364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The use of adjuvants in the specific desensitizing therapy of allergic states].
    Dal Bo S
    Folia Allergol (Roma); 1970; 17(3):295-308. PubMed ID: 5517221
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunomorphology of sensitization. VII. Effect of heterologous sensitization on the kinetics of experimental tuberculous inflammation].
    Eskenasy A; Ionescu J; Galbenu P
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):265-73. PubMed ID: 4936241
    [No Abstract]   [Full Text] [Related]  

  • 29. [A review of clinical tumor immunology. An approach to immunochemotherapy].
    Hattori T
    Nihon Gan Chiryo Gakkai Shi; 1974 Nov; 9(4):381-90. PubMed ID: 4616062
    [No Abstract]   [Full Text] [Related]  

  • 30. Incomplete Freund's adjuvant enhances locomotor performance following spinal cord injury.
    Azari MF; Karnezis T; Bernard CC; Profyris C; LeGrande MR; Zang DW; Cheema SS; Petratos S
    Eur J Neurol; 2005 Dec; 12(12):1004-8. PubMed ID: 16324097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incomplete Freund's adjuvant reduces diabetes in the non-obese diabetic mouse.
    Liddi R; Beales PE; Rosignoli G; Pozzilli P
    Horm Metab Res; 2000 Jun; 32(6):201-6. PubMed ID: 10898548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice.
    Tal Y; Souan L; Cohen IR; Meiner Z; Taraboulos A; Mor F
    J Neurosci Res; 2003 Jan; 71(2):286-90. PubMed ID: 12503092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of 4-hydroxypentenal on Harding-Passey melanoma of the mouse].
    Krings R; Tritsch H
    Arch Dermatol Forsch; 1973 Mar; 246(2):108-13. PubMed ID: 4699522
    [No Abstract]   [Full Text] [Related]  

  • 34. Modulation of the immune response to transplantation antigens. III. Further studies on the effects of Freund's complete adjuvant on the immune response of mice to allogeneic tumour antigen.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):469-79. PubMed ID: 4157121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in the protective effect of complete Freund's adjuvant in spontaneous versus transplanted lymphomas in AKR mice.
    Check JH; Brady LW; O'Neill EA
    Prog Exp Tumor Res; 1974; 19():217-21. PubMed ID: 4438641
    [No Abstract]   [Full Text] [Related]  

  • 36. A FORWARD LOOK AT VIRAL VACCINES: WITH SPECIAL REFERENCE TO A NEW IMMUNOLOGIC ADJUVANT.
    HILLEMAN MR
    Am Rev Respir Dis; 1964 Nov; 90():683-706. PubMed ID: 14211456
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunomodulation of low dose streptozocin diabetes in mice reveals that insulitis is not obligatory for B cell destruction.
    Papaccio G; Chieffi Baccari G; Esposito V
    J Anat; 1992 Dec; 181 ( Pt 3)(Pt 3):403-7. PubMed ID: 1304577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of type 1 diabetes in mice.
    Melton DA
    N Engl J Med; 2006 Jul; 355(1):89-90. PubMed ID: 16823003
    [No Abstract]   [Full Text] [Related]  

  • 39. [Method of regulating specific immunity in acute leukemia. 1. Experimental and theoretical grounds of the method].
    Bergol'ts VM; Moskovkina OIa; Sukhin GM; Kovalev BN; Eremeev VS
    Pediatriia; 1978 Jul; (7):9-13. PubMed ID: 673617
    [No Abstract]   [Full Text] [Related]  

  • 40. Prolonged survival of mouse ependymoma hosts after immunization with ribosomal complexes.
    Lo JS; Kellen JA
    Biomedicine; 1974 Aug; 21(8):329-33. PubMed ID: 4441592
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.